Aterian (NASDAQ:ATER) Lowered to Sell Rating by Wall Street Zen

Wall Street Zen downgraded shares of Aterian (NASDAQ:ATER) from a hold rating to a sell rating in a report issued on Saturday morning.

Separately, Weiss Ratings upgraded Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 19th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Aterian Price Performance

NASDAQ ATER opened at $0.40 on Friday. The firm has a market capitalization of $4.36 million, a price-to-earnings ratio of -0.16 and a beta of 0.68. The company’s fifty day moving average is $1.18 and its two-hundred day moving average is $0.88. Aterian has a 52-week low of $0.40 and a 52-week high of $1.87.

Aterian (NASDAQ:ATER) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.39) EPS for the quarter, beating analysts’ consensus estimates of ($0.69) by $0.30. Aterian had a negative net margin of 39.56% and a negative return on equity of 82.05%. The business had revenue of $0.02 million during the quarter, compared to analyst estimates of $15.82 million.

Institutional Investors Weigh In On Aterian

Several institutional investors and hedge funds have recently bought and sold shares of ATER. Citadel Advisors LLC lifted its holdings in shares of Aterian by 222.0% during the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after acquiring an additional 22,865 shares during the period. Susquehanna International Group LLP boosted its position in shares of Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after acquiring an additional 30,637 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Aterian by 73.0% in the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after acquiring an additional 9,026 shares during the period. Finally, XTX Topco Ltd bought a new stake in Aterian in the second quarter valued at about $55,000. Institutional investors own 7.02% of the company’s stock.

About Aterian

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.